Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 30;143(25):9672-9681.
doi: 10.1021/jacs.1c04786. Epub 2021 Jun 17.

Quantitative Exchange NMR-Based Analysis of Huntingtin-SH3 Interactions Suggests an Allosteric Mechanism of Inhibition of Huntingtin Aggregation

Affiliations

Quantitative Exchange NMR-Based Analysis of Huntingtin-SH3 Interactions Suggests an Allosteric Mechanism of Inhibition of Huntingtin Aggregation

Alberto Ceccon et al. J Am Chem Soc. .

Abstract

Huntingtin polypeptides (httex1), encoded by exon 1 of the htt gene and containing an expanded polyglutamine tract, form fibrils that accumulate within neuronal inclusion bodies, resulting in the fatal neurodegenerative condition known as Huntington's disease. Httex1 comprises three regions: a 16-residue N-terminal amphiphilic domain (NT), a polyglutamine tract of variable length (Qn), and a polyproline-rich domain containing two polyproline tracts. The NT region of httex1 undergoes prenucleation transient oligomerization on the sub-millisecond time scale, resulting in a productive tetramer that promotes self-association and nucleation of the polyglutamine tracts. Here we show that binding of Fyn SH3, a small intracellular proline-binding domain, to the first polyproline tract of httex1Q35 inhibits fibril formation by both NMR and a thioflavin T fluorescence assay. The interaction of Fyn SH3 with httex1Q7 was investigated using NMR experiments designed to probe kinetics and equilibria at atomic resolution, including relaxation dispersion, and concentration-dependent exchange-induced chemical shifts and transverse relaxation in the rotating frame. Sub-millisecond exchange between four species is demonstrated: two major states comprising free (P) and SH3-bound (PL) monomeric httex1Q7, and two sparsely populated dimers in which either both subunits (P2L2) or only a single subunit (P2L) is bound to SH3. Binding of SH3 increases the helical propensity of the NT domain, resulting in a 25-fold stabilization of the P2L2 dimer relative to the unliganded P2 dimer. The P2L2 dimer, in contrast to P2, does not undergo any detectable oligomerization to a tetramer, thereby explaining the allosteric inhibition of httex1 fibril formation by Fyn SH3.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1.
Figure 1.
Inhibition of aggregation and fibril formation of httex1Q35 by Fyn SH3. (A) Time course of the integrated intensity of the amide proton envelope of 0.1 mM httex1Q35 in the absence (red) and presence (blue) of 3 mM Fyn SH3, obtained from the first increment of serial 1H–15N correlation experiments recorded at 600 MHz and 5 °C. The inset is a picture of the NMR tubes after 70 h in the absence (left) and presence (right) of SH3. (B) Negative stain EM of the NMR sample after 70 h in the presence of SH3. (C) Concentration dependence of aggregation kinetics of httex1Q35 monitored by ThT fluorescence at 37 °C. (D) Effect of SH3 on aggregation of 50 μM httex1Q35 monitored by ThT fluorescence at 37 °C.
Figure 2.
Figure 2.
Chemical shift perturbation mapping of interaction sites between httex1Q7 and Fyn SH3. (A) Weighted 1HN/15N perturbation profile (ΔδH/N = {[ΔδN2/52 + ΔδH2]/2}1/2) obtained for 0.16 mM 15N-labeled SH3 in the presence of 0.56 mM unlabeled httex1Q7. The inset shows the ΔδH/N values for the side chain nitrogen atoms of W36 and N53. (B) Model of polyproline P11 binding to Fyn SH3 derived from the NMR structure of a SH3-polyproline-containing peptide complex (PDB code 1AZG); side chains of residues with ΔδH/N > 0.22 ppm are colored in red (see Experimental Section for details of modeling). (C) ΔδH/N profile for 0.1 mM 15N/13C-labeled httex1Q7 in the presence of 0.4 mM SH3. The domain organization of httex1Q7 is depicted above the plot, and the inset shows progressive line broadening of 13C cross sections through the 1H/13Cα cross-peaks of the prolines upon addition of SH3. All NMR data were recorded at 5 °C at either 600 (A) or 900 (C) MHz.
Figure 3.
Figure 3.
Quantitative analysis of the kinetics and equilibria of Fyn SH3 binding to httex1Q7 and subsequent dimerization. (A) Examples of the dependence of δex and R2,eff (at two spin lock fields, 750 and 3000 Hz) measured for 0.1 mM 15N/13C-labeled httex1Q7 on the concentration of added unlabeled SH3. The data were acquired at 900 MHz. (B) Examples of 15N (800 MHz) and 13Cα (600 and 800 MHz) CPMG relaxation dispersion profiles for 0.3 mM 15N/13Cα-labeled httex1Q7 in the presence of 0.3 mM (15N and 13Cα) and 0.6 (15N) mM unlabeled SH3. (C) 15N-δex observed at 800 MHz for 0.3 mM 15N/13Cα-labeled httex1Q7 in the presence of 0.3 mM unlabeled SH3. (D) Examples of the dependence of 15N- and 1HN-δex measured at 600 MHz for 0.16 mM 15N-labeled SH3 on the concentration of added unlabeled httex1Q7. The experimental data are shown as circles in panels A, B, and D and as filled-in red circles in panel C; the global best-fit curves to the scheme shown in Figure 4 are displayed as continuous lines in panels A, B and D, and as filled-in blue circles in panel C. All data were recorded at 5 °C. The complete experimental data sets and best-fit curves are provided in Figures S3–S6.
Figure 4.
Figure 4.
Scheme for the binding of Fyn SH3 to httex1Q7 and subsequent dimerization viewed from the perspective of (A) httex1Q7 and (B) Fyn SH3. The bold font is used to denote magnetization of the isotopically labeled species. Δωi are the differences in chemical shift to the major NMR observable, either monomeric httex1Q7 (P) or free SH3 (L). ki and ki are second-order association and first-order dissociation rate constants, respectively, and k–4 = (k1k4k–3k–2)/(k–1k2k3). The prefactors in front of the rate constants relate to the differential equations (eq 1) describing the time-dependence of magnetizations. The species populations, shown in parentheses in panel A, relate to 0.1 mM httex1Q7 in the presence of 0.3 mM SH3.
Figure 5.
Figure 5.
15N and 13Cα Δω profiles within the NT region of httex1Q7 attributable to binding of Fyn SH3 (ΔωB) to the first polyproline tract of the PRD and to dimerization of the NT (ΔωD) obtained from the global fit to the experimental NMR data. The ΔωB and ΔωD values are displayed as gray and black circles, respectively. Note that Gln19 exhibits no observable 13Cα exchange-induced shifts or 13Cα-CPMG relaxation dispersion.
Figure 6.
Figure 6.
Simulation of the populations of free monomer httex1Q7 (P) and monomeric (PL) and dimeric (P2L and P2L2) states of SH3-bound httex1Q7 as a function of total Fyn SH3 concentration. (A) [P]total = 0.1 or 0.3 mM with [SH3]total up to 0.6 mM. (B) [P]total = 0.1 mM with [SH3]total up to 3 mM. Note the population scale on the left panels ranges from 0 to 100%, while that on the right panels is from 0% to 6%. The equilibrium dissociation constants for the four-state binding scheme are given in Table 1.
Figure 7.
Figure 7.
Probing putative tetramerization of httex1Q7 in the presence of Fyn SH3. (A) Scheme for the oligomerization of httex1Q7 upon binding of SH3 that considers the existence of a putative tetramer P4L4 formed by self-association of the P2L2 dimer and characterized by the equilibrium dissociation constant KD5. The expression for the dependence of the population of P4L4 on the population of the bound monomer PL is provided. For simplicity the singly bound dimer, P2L, shown in the scheme of Figure 4A has been omitted, as its equilibrium population is ~20 times smaller than that of P2L2. (B) Examples of the dependence of 15N-δex on the concentration of 15N/13C-labeled httex1Q7 in the presence of 5 mM SH3. The experimental data, recorded at 800 MHz and 5 °C, are displayed as red circles, and simulations of 15N-δex for a range of values of KD5 are shown as dashed lines. The calculated curve for KD5 ≥ 1 mM (red continuous line) is indistinguishable from that without tetramerization. Simulations were performed using the values of the rate constants provided in Table 1 and the values of ΔωB and ΔωD reported in Table S1. The 15N chemical shifts within the NT region of the P2L2 dimer and P4L4 tetramer were assumed to be the same (i.e., ΔωP4L4=ΔωP2L2=ΔωB+ΔωD). The populations indicated above the species in panel A correspond to those at the highest concentration of httex1Q7 (0.4 mM) employed in the experiments with a SH3 concentration of 5 mM. Under these conditions the population of free httex1Q7 (P) is only ~5%.

References

    1. Andresen JM; Gayan J; Djousse L; Roberts S; Brocklebank D; Cherny SS; Group US-VCR; Group HMCR; Cardon LR; Gusella JF; MacDonald ME; Myers RH; Housman DE; Wexler NS The Relationship between CAG Repeat Length and Age of Onset Differs for Huntington’s Disease Patients with Juvenile Onset or Adult Onset. Ann. Hum. Genet 2007, 71, 295–301. - PubMed
    1. Ross CA; Tabrizi SJ Huntington’s Disease: From Molecular Pathogenesis to Clinical Treatment. Lancet Neurol. 2011, 10, 83–98. - PubMed
    1. Bates GP; Dorsey R; Gusella JF; Hayden MR; Kay C; Leavitt BR; Nance M; Ross CA; Scahill RI; Wetzel R; Wild EJ; Tabrizi SJ Huntington Disease. Nat. Rev. Dis. Primers 2015, 1, 15005. - PubMed
    1. Landles C; Sathasivam K; Weiss A; Woodman B; Moffitt H; Finkbeiner S; Sun B; Gafni J; Ellerby LM; Trottier Y; Richards WG; Osmand A; Paganetti P; Bates GP Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease. J. Biol. Chem 2010, 285, 8808–8823. - PMC - PubMed
    1. Sathasivam K; Neueder A; Gipson TA; Landles C; Benjamin AC; Bondulich MK; Smith DL; Faull RL; Roos RA; Howland D; Detloff PJ; Housman DE; Bates GP Aberrant Splicing of HTT Generates the Pathogenic Exon 1 Protein in Huntington Disease. Proc. Natl. Acad. Sci. U. S. A 2013, 110, 2366–2370. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources